We investigated whether agaro-oligosaccharides have any immunological effects on RAW264.7 mouse macrophages and human monocytes in vitro. We demonstrate that agaro-oligosaccharides suppressed the elevated levels of nitric oxide, prostaglandin E 2 , and such proinflammatory cytokines as tumor necrosis factor-, interleukin-1 and interleukin-6 in lipopolysaccharidestimulated monocytes and macrophages. We also demonstrate that those effects of agaro-oligosaccharides on activated monocytes and macrophages may have been caused by heme oxygenase-1 induction. It is therefore proposed that agaro-oligosaccharides might be a good candidate for a functional food to prevent inflammatory diseases.
Agar is an edible polysaccharide contained in red algae, and has been consumed in Asian countries, particularly in Japan, for more than 300 years. Agarose, the main component of polysaccharides in agar, is composed of the alternating residues of 3-O-linked -Dgalactopyranose (Gal) and 4-O-linked 3,6-anhydro--Lgalactopyranose (Ah-Gal).
1) The 1-3 linkage of agarose is easily hydrolyzed under acidic conditions, yielding AGOs that have repeating agarobiose (AB) units, with Gal at the non-reducing end and Ah-Gal at the reducing end ( Fig. 1) . We explored the dietary functions of AGOs and particularly their anti-inflammatory activity.
The release of activated oxygen and pro-inflammatory cytokines by activated neutrophils and macrophages has been implicated in the pathogenesis of inflammatory diseases such as rheumatoid arthritis (RA), because the effect of those molecules results in the destruction of tissue. 2, 3) It has also been reported that the serum nitric oxide (NO) level is elevated in the synovium of RA patients, 4) and excessive NO contributes to inflammation-related carcinogenesis.
5) The activated macrophages at the sites of inflammation persistently express inducible NO synthase (iNOS), resulting in the production of a large amount of NO which interacts with other free radicals (superoxide anions) to form the highly toxic peroxynitrite. 6) Such pro-inflammatory cytokines as tumor necrosis factor (TNF)-, interleukin (IL)-1 and IL-6 are also produced by activated macrophages and are involved in the pathogenesis of RA and carcinogenesis. 7, 8) Furthermore, cyclooxygenase-2 (COX-2) expression is induced by IL-1 in the synovial tissue of RA patients. 9 ) PGE 2 produced by COX-2 increases the blood flow and potentiates edema and hyperalgesia.
10) It has also been suggested that PGE 2 may contribute to colon tumorigenesis.
11)
The aim of this study is to demonstrate whether AGOs exert inhibitory activities on the production of pro-inflammatory mediators in LPS-stimulated murine macrophages and human monocytes. To the best of our knowledge, there have been few studies that document the anti-inflammatory effects of dietary oligosaccharides.
Materials and Methods
Reagents. Bacterial LPS (Escherichia coli 055:B5) and neoagarohexaose were purchased from Sigma Chemicals (St. Louis, MO, USA). Recombinant mouse IFN-and various EIA kits were purchased from R&D Systems (Minneapolis, MN, USA).
Cell culture. The RAW264.7 mouse macrophage-like cell line (ATCC TIB71) was acquired from Dainippon Sumitomo Pharma (Osaka, Japan). The cells were cultured in DMEM supplemented with 10% FBS (JRH Biosciences, Lenexa, KS, USA) and antibiotics, and passaged every 3 d. The cells for the various assays were suspended in the culture medium to give 2{4 Â 10 5 cells/ml and placed in a 6, 12 or 48-well plate. The assays were conducted after an overnight culture.
Preparation of AGOs. Agar was suspended in 0.1 N HCl to 10% (w/v) and heated at 100 C for 15 min. After removing the insoluble materials, the AGO solution was subjected to gel filtration chromatography in a Toyopearl HW-40C column (45 mm dia. Â 100 cm, Tosoh, Tokyo, Japan) at the rate of 1 ml/min with pure water as the carrier to separate the variously sized AGOs. The AGO fractions were identified by TLC, using silica gel 60 F 254 (Merck, Darmstadt, Germany) with butanol:ethanol:water (5:3:3) as the solvent system. Nitrite assay. RAW264.7 macrophages were stimulated with 1 mg/ml of LPS for 14-18 h. AGOs were simultaneously added to the cells or 6 h before stimulation. The culture supernatant was used for the nitrite assay. Nitrite accumulation in the culture medium was measured as an index of cellular NO synthesis. 12) This was spectroy To whom correspondence should be addressed. Fax: +81-77-543-2494; E-mail: enokit@takara-bio.co.jp Abbreviations: NO, nitric oxide; PGE 2 , prostaglandin E 2 ; TNF-, tumor necrosis factor-; IL-1, interleukin-1; IL-6, interleukin-6; HO-1, heme oxygenase-1; LPS, lipopolysaccharide; IFN-, interferon-; iNOS, inducible NO synthase; AGOs, agaro-oligosaccharides; AB, agarobiose; RA, rheumatoid arthritis; COX-2, cyclooxygenase-2; PBMCs, peripheral blood mononuclear cells; siRNA, small interfering RNA; ROS, reactive oxygen species; CO, carbon monoxide photometrically assessed by adding 100 ml of the Griess reagent (Sigma) to an equal volume of the sample medium. After 10 min of incubation, the absorbance of the mixture was measured at 540 nm by a plate reader, with a sodium nitrite solution used as the standard.
Western blot analysis. RAW264.7 macrophages were stimulated for 12 h with 1 mg/ml of LPS with or without 10 U/ml of IFN-. AGOs were simultaneously added to cells or 6 h before stimulation. The cells were then suspended in an extraction buffer (0.1% Triton X-100, 10 mM EDTA-2Na, 1 mM PMSF, 0.2 mM leupeptin, and 0.05 mM pepstatin A in 100 mM Tris-HCl at pH 7.4), and disrupted by one freezing-thawing cycle. The lysate was centrifuged at 10;000 Â g for 20 min at 4 C and the supernatant was collected. The protein concentration of each sample was determined by a Micro-BCA protein assay reagent (Pierce Chemical Co., Rockford, IL, USA). The cell extract containing 10 mg of protein was mixed with an equal volume of a Laemmli loading buffer and boiled for 5 mins. The sample was loaded for 7.5% or 12.5% SDS-PAGE, and the proteins were electrotransferred to a PVDF membrane (Nihon Millipore, Tokyo, Japan) according to the manufacturer's instructions. The target proteins were detected by their respective antibodies, anti-iNOS mAb (Transduction Laboratories, Lexington, KY, USA), anti-HO-1 polyclonal Ab, anti-HSP (heat shock protein) 70 mAb and anti-GRP (glucose-regulated protein) 78 polyclonal Ab (Santa Cruz Biotechnology, Santa Cruz, CA, USA), and anti--tubulin mAb (EMD Biosciences, San Diego, CA, USA), before being visualized by chemiluminescence using secondary detection antibodies.
Isolation of monocytes from human peripheral blood mononuclear cells (PBMCs). PBMCs that had been obtained under informed consent were purchased from Cambrex (Walkersville, MD, USA). The PBMCs were suspended at 2 Â 10 6 cells/ml in an RPMI1640 medium containing 5% human AB serum, 0.1 mM non-essential amino acids, 1 mM sodium pyruvate, 2 mM L-glutamine, 10 mM HEPES and antibiotics (the 5H RPMI medium). The cells were plated in 24-well plates at 1 ml/well and then incubated for 1.5 h. The non-adhering cells were then removed, and each well was washed with RPMI1640, before adding 1 ml of the 5H RPMI medium prior to the assay.
RNA interference. HO-1 siRNAs (small interfering RNAs) were synthesized by Takara Bio (Otsu, Japan) comprising a 19-base duplex RNA nucleotide sequence with two 3 0 deoxythymidine residues (HO-1 siRNA, 5 0 -CACUCUACUUCCCUGAGGAtt-3 0 ; and the control, 5 0 -UUACCCGUUGCGCAACACUtt-3 0 ). siRNA was transfected with TransIT TKO (Mirus, Madison, WI, USA) according to the manufacturer's instructions. Fifty nM duplex in 150 ml of OptiMEM (Invitrogen Japan, Tokyo, Japan) was added to each well. A fresh medium was added after an overnight culture, and the assays were conducted.
Quantitative real-time (RT)-PCR. Total RNA was extracted by using the Trizol reagent (Invitrogen) to determine relative HO-1 mRNA. Reverse transcription was performed with AMV reverse transcriptase and random hexamers (Takara Bio). Synthesized cDNA was used for HO-1 mRNA quantification by RT-PCR. The PCR primers used for mouse or human HO-1 and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as a house-keeping control gene were from the Perfect Realtime system (Takara Bio). Each reaction was performed with a SmartCycler (Takara Bio), using SYBR Premix ExTaq (Takara Bio). The gene expression levels were normalized to GAPDH and are presented as arbitrary units. PGE 2 and cytokine analyses. RAW264.7 macrophages or human monocytes were stimulated for 18 h with 1 mg/ml (RAW) or 1 ng/ml (monocytes) of LPS. AGOs were simultaneously added to the cells or 5 h before stimulation. The culture supernatant was collected, and the PGE 2 (Neogen, Lexington, KY, USA), TNF-, IL-1 and IL-6 contents were determined by using each EIA kit.
Statistical analyses. Statistical analyses were performed with StatLight#4 software (Yukms, Tokyo, Japan). Differences in mean values were statistically evaluated by Williams's test and Student's t-test.
Results

Attenuation of NO and PGE 2 production, and suppression of iNOS expression by AGOs
Treating the macrophages with LPS increased the nitrite production by about 59-107-fold (about 35.4-36.3 mM), as compared to the untreated macrophages (about 0.33-0.61 mM). When the unstimulated cells were cultured with AGOs alone, the accumulation of nitrite was maintained at the same low level as that with the unstimulated culture (about 0.37-0.74 mM). The addition of AGOs and subsequent treatment with LPS resulted in dose-dependent inhibition of the nitrite accumulation. About 63% nitrite reduction by agarobiose (AB), 57% reduction by agarotetraose (AT) and 58% reduction by agarohexaose (AH) (Fig. 2A, B , and C, respectively) resulted at the highest dose of each 200 mM AGO. Regardless of the length of each oligosaccharide, AB, AT and AH showed similar inhibition of NO generation. On the other hand, neoagarohexaose (NAH), having D-galactose at the reducing end, had no effect on NO production, even at 1 mM (Fig. 2D) inhibited PGE 2 production in LPS-primed macrophages in a dose-dependent manner (Fig. 2E ). RAW264.7 cells did not express a detectable level of iNOS protein after 12 h of incubation with the medium alone. In contrast, iNOS protein was markedly induced in the LPS-treated macrophages, and decreased by treating with AB in a dose-dependent manner. Combined stimulation with LPS and IFN-slightly reduced the iNOS abundance in the presence of AB. However, when pre-incubation with AB was carried out for 6 h prior to combined LPS and IFN-stimulation, a significant reduction of iNOS was observed (Fig. 3) . These results indicate that AGOs suppressed the iNOS expression, and then NO synthesis was inhibited in the activated macrophages. Moreover, the inhibitory effect was enhanced by pre-incubating AGOs prior to the stimulation.
Heme oxygenase-1 (HO-1) induction by AB It has been reported that iNOS activation in LPSstimulated macrophages was suppressed by CO and iron ions produced by heme oxygenase-1. 13, 14) To characterize the mechanism for the inhibition of nitrite production by AB, we examined whether AB could induce HO-1 protein in RAW264.7 cells. As shown in Fig. 4 , RAW264.7 macrophages did not express a detectable level of HO-1 protein after 12 h of incubation with the medium alone, LPS or LPS plus IFN-. However, the addition of AB resulted in a dramatic induction of HO-1 protein in a dose-dependent manner. This induction was also confirmed when AB was simultaneously added with the stimulus. Neither the stimulating agent nor AB affected the levels of both HSP70 and GRP78 that are also stress-responsible proteins similar to HO-1.
Attenuation by HO-1 siRNAs of the inhibitory effects of AGOs on nitrite and PGE 2 production in LPSstimulated cells
We examined the nitrite and PGE 2 levels when HO-1 siRNAs were added to clarify the role of HO-1 induction by AGOs. It was confirmed by quantitative the RT-PCR method that HO-1 induction by AGOs was repressed by HO-1 siRNAs to the basal level (Fig. 5A ). As shown in Fig. 5B , the addition of HO-1 siRNAs, compared with control siRNAs, resulted in an attenuation of the inhibitory effect of AGOs on nitrite production in LPSstimulated cells. On the other hand, no difference was apparent between HO-1 siRNAs and control siRNAs in the nitrite level from LPS stimulation alone. Similarly, the inhibitory effects of AGOs on PGE 2 production were diminished in HO-1 siRNA-treated cells, while there was no effect on control siRNA (Fig. 5C ). These data suggest that the inhibitory effects of AGOs on nitrite and PGE 2 production in activated macrophages resulted at least partially from HO-1 induction. RAW264.7 macrophages were incubated with the indicated concentrations of AB in the presence or absence of LPS (1 mg/ml) or LPS plus IFN-(10 U/ml). After the cells had been incubated for 12 h, cell extracts were prepared and analyzed by western blotting.
Inhibition by AB of pro-inflammatory cytokine production in LPS-primed human monocytes
Carbon monoxide (CO) produced by heme digestion with HO-1 has been reported to have anti-inflammatory activity. 15) We therefore tested for the ability of AB to inhibit pro-inflammatory cytokine production in LPSstimulated human monocytes. The HO-1 expression level was also significantly increased in human monocytes by the addition of AB (about 6-fold vs. the control, Fig. 6A ). Such pro-inflammatory cytokines as TNF-, IL-1 and IL-6 were abundantly generated in LPSstimulated monocytes (Fig. 6) . In contrast, the addition of AB prior to LPS stimulation led to dose-dependent inhibition of the production of pro-inflammatory cytokines. The addition of 100 mM AB resulted in a decrease in the production of TNF-(64%), IL-1 (100%), and IL-6 (91%) (Fig. 6A, B, and C, respectively) .
After taking everything into consideration, we reached the conclusion that AB inhibited the release of pro-inflammatory cytokines through an HO-1-dependent pathway.
Discussion
This study reports that AGOs derived from the typical oriental food, agar, had inhibitory activities correlated with the induction of HO-1 expression toward the production of NO, PGE 2 and various pro-inflammatory cytokines in LPS-stimulated mouse macrophages or human monocytes.
We first examined whether AGOs had any inhibitory activity toward NO production in LPS-stimulated RAW264.7 murine macrophages. Such AGOs as agarobiose, agarotetraose and agarohexaose, having 3,6-anhydro-L-galactose at the reducing end, inhibited nitrite accumulation in a dose-dependent manner. In contrast, neo-agarohexaose, having D-galactose at the reducing end, had no effect on NO production. Furthermore, 3,6-anhydro-L-galactose exhibited weak inhibition, while D-galactose had no activity (data not shown). Taking all these results into consideration, 3,6-anhydro-L-galactose at the reducing end of AGOs might play a crucial role in the inhibition of NO production.
The inhibitory activity of AGOs toward excess NO production had been thought to result from decreased iNOS expression, but this activity was counteracted by IFN-. However, pre-incubating with AGOs overcame the inhibition by IFN-. We therefore hypothesize that AGOs may induce protein that could inhibit NO production in stimulated macrophages and that may be repressed by IFN-. Indeed, we found that HO-1 protein was induced by AB in a dose-dependent manner in RAW264.7 macrophages and human monocytes. HO-1 catalyzes the breakdown of heme into equimolar amounts of CO, iron and biliverdin. 16) Iron regulates iNOS transcription, while CO inhibits iNOS enzyme activity. 13, 14) A previous study has also revealed that IFN-repressed the expression of HO-1. 17) Biliverdin, one of the heme degradation products, is metabolized to bilirubin which is a potent antioxidant. 18) Bilirubin may remove reactive oxygen species (ROS) and prevent worsening of the lesions at inflammatory sites. HO-1 induced by AGOs may therefore be effective for removing ROS produced by neutrophils as well as inhibiting NO production by macrophages in a chronic inflammation site involving RA lesions. Indeed, the beneficial effects of HO-1 on various inflammatory diseases (e.g., RA, colitis and ischemia/reperfusion injury) have been reported. [19] [20] [21] [22] [23] Choi et al. 15) have reported that CO suppressed the production of such pro-inflammatory cytokines as TNF-, IL-1, MIP-1 and MIP-2 in activated macrophages. In fact, AB inhibited the generation of these cytokines in LPS-stimulated human monocytes. Whether AB inhibits all of these pro-inflammatory cytokines by a CO function is currently unclear. However, it is suggested that HO-1 is sufficiently induced and CO is produced, thereby suppressing the pro-inflammatory cytokines, because HO-1 was markedly induced by AB in human monocytes and because the inhibitory effects of AB on NO and PGE 2 production were attenuated by the addition of HO-1 siRNAs.
AGOs are therefore expected to show their beneficial effects via HO-1 induction on subjects having diseases caused by chronic inflammation. However, it is currently unclear whether AGOs can elicit anti-inflammatory activity in vivo by contacting activated monocytes/ macrophages at an inflammation site, since a high dose of AGOs was needed to inhibit the release of proinflammatory mediators in an in vitro study. Future studies should therefore investigate the anti-inflammatory effects in an animal study such as one involving the arthritis model. The results of our preliminary studies indicate that AGOs had a preventive effect on collageninduced arthritis. Further detailed examinations are needed to address the mechanism of action of AGOs.
The results from the present study suggest that AGOs from agar, which is a traditional food in Japan, may provide a useful functional food for preventing and/or treating inflammatory diseases such as RA.
